Unbiased AI-powered news
2 stories related to this topic, newest first.
BenzingaRAD Intel is offering shares at $0.91 each through a Regulation A+ investment round. The company operates an AI-driven marketing platform paired with an Artificial Intelligence Buyout Strategy. It has reported raising over $75 million and a 4,900% valuation growth over four years…
Substrate placeholder — needs reviewOutlook Therapeutics has announced a $5 million registered direct offering priced at $0.31 per share, including warrants. The offering is expected to close on April 23, 2026. This move provides the company with additional capital through a direct sale of securities.